MAJOR DEPRESSIVE DISORDER
Clinical trials for MAJOR DEPRESSIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MAJOR DEPRESSIVE DISORDER trials appear
Sign up with your email to follow new studies for MAJOR DEPRESSIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom brain zaps tested for Hard-to-Treat depression
Disease control CompletedThis study tested whether customizing a non-invasive brain stimulation treatment could work better for people with depression that hasn't responded to medication. Researchers compared three versions of the treatment in 75 participants over four weeks. They measured changes in bra…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 04, 2026 00:21 UTC
-
Zapping depression away: new brain stimulation trial offers hope
Disease control CompletedThis study tested a new way to treat severe depression that doesn't get better with standard medications. Researchers used a gentle electrical current applied to the scalp, given in a more intense and frequent pattern than usual, to see if it could reduce symptoms. A small group …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 04, 2026 00:21 UTC
-
Scientists zap depression with targeted brain stimulation paired with therapy
Disease control CompletedThis study tested a new approach for treating major depression that combines two treatments. Researchers used MRI scans to precisely target a brain stimulation treatment (rTMS) while participants also did a computer-based talk therapy session. The goal was to see if doing both tr…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New depression drug shows early promise in mood and alertness
Disease control CompletedThis study tested an experimental drug called ALTO-203 in people with moderate depression and loss of pleasure (anhedonia). Researchers gave 69 participants either the drug or a placebo to see how it affected their mood and alertness, and to check if it was safe. The goal was to …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Ketamine tested as Fast-Acting hope for teens with untreatable depression
Disease control CompletedThis study tested whether a low-dose ketamine infusion could quickly reduce depression symptoms in teenagers whose depression had not improved with standard antidepressants. Researchers compared the ketamine infusion to a placebo (saltwater) infusion in a small group of adolescen…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE4 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Add-On pill tested for Hard-to-Treat depression
Disease control CompletedThis study tested whether adding an experimental oral medication called SPN-820 could help adults with major depressive disorder who were already taking a standard antidepressant but still had significant symptoms. The 40 participants took SPN-820 every three days for 10 days in …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for Tough-to-Treat depression?
Disease control CompletedThis study tested whether adding a new medication called SEP-363856 to a person's current antidepressant could help reduce depression symptoms more effectively. It involved 929 adults whose depression had not improved enough with standard antidepressants alone. Researchers compar…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Brain zap shortcut? study tests faster depression treatment
Disease control CompletedThis small, early study explored a faster version of a non-invasive brain stimulation treatment for depression. It involved 11 patients and gathered feedback from clinic staff. The goal was to see if delivering the treatment more quickly was acceptable and could reduce symptoms, …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Brain zaps show promise against tough depression cases
Disease control CompletedThis study tested whether a type of non-invasive brain stimulation called theta burst stimulation (TBS) could help people with moderate to severe depression who haven't fully responded to standard treatments. 238 participants received either real TBS or a sham (fake) treatment fo…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New depression pill tested for quicker relief
Disease control CompletedThis study tested whether an investigational medicine called NBI-1070770 could help improve symptoms of major depression when added to a person's current antidepressant. 73 adults with depression took either the new medicine or a placebo pill for a short period. The main goal was…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug tested for Hard-to-Treat depression symptom
Disease control CompletedThis study tested a new drug called ENX-104 in people with major depression who also experience anhedonia, which is a loss of interest or pleasure. The main goal was to see if the drug was safe and how the body processes it. The study involved 48 participants and was an early-sta…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1 • Sponsor: Engrail Therapeutics INC • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Personalized depression drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether ALTO-100, a new investigational medication, helps reduce symptoms of major depression. It involved 301 adults with moderate to severe depression, who took the drug either by itself or added to their current antidepressant for 6 weeks. Researchers measure…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New depression pill shows early promise in clinical trial
Disease control CompletedThis study tested an experimental oral medication called GM-1020 in people with moderate to severe depression. The main goals were to check if the drug is safe and well-tolerated, and to look for early signs that it might help reduce depression symptoms. The trial involved 46 adu…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Can a job coach help you beat depression and get back to work?
Disease control CompletedThis study tested whether a special job support program could help people with depression or anxiety return to work or school. 326 adults who were unable to work due to their condition received either the job coaching plus their usual treatment, or just their usual treatment. Res…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Amager Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists aim to boost depression treatment by Fine-Tuning brain targets
Disease control CompletedThis study tested whether customizing where a non-invasive brain stimulation treatment is aimed could make it more effective for depression. Researchers worked with 50 adults diagnosed with major depression, comparing personalized targeting methods against standard approaches dur…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Stem cell shot tested for dual battle with booze and blues
Disease control CompletedThis study tested whether an infusion of donor stem cells is safe and might help people who struggle with both heavy drinking and major depression. Thirty-one participants were randomly assigned to receive either the stem cell treatment or a placebo infusion. Researchers monitore…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Ihsan M Salloum, MD, MPH • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New depression Drug's safety tracked in 800+ patients
Disease control CompletedThis study aimed to check the long-term safety of adding a new medication called lumateperone to standard antidepressant therapy for people with major depression. Over 800 patients who had already completed a prior study took lumateperone daily for about six months while continui…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Could a hot sauna be the key to cooling depression?
Disease control CompletedThis study explored whether adding whole-body heat therapy (like a medical sauna) to standard cognitive behavioral therapy (CBT) could help people with major depression. Thirty adults with depression received eight weeks of CBT and were randomly assigned to also get either real o…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New depression drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether a new drug called BHV-7000 could safely reduce symptoms of major depression. It involved 336 adults with moderate to severe depression who were not taking other depression medications. Researchers compared the drug to a placebo over 6 weeks, measuring ch…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New depression pill shows promise in major clinical trial
Disease control CompletedThis completed Phase 3 study tested whether an investigational oral medication called NMRA-335140 could reduce symptoms of major depression compared to a placebo. The 6-week trial involved 383 adults with moderate to severe depression who were randomly assigned to receive either …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Magnetic brain zaps tested as new hope for tough depression cases
Disease control CompletedThis study tested whether a new pattern of magnetic brain stimulation works as well as the current standard method for treating major depression. It involved 104 adults with depression who hadn't gotten enough relief from antidepressant medications. Researchers compared the new s…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Brainsway • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Brain zap + online therapy: a new hope for tough depression?
Disease control CompletedThis study tested if combining two depression treatments works better than one. 40 people with major depression received a brain stimulation treatment called TMS. Half also got an online therapy program to see if the combination improved their symptoms more than TMS alone.
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New depression drug shows promise in major trial
Disease control CompletedThis study tested whether a medication called solriamfetol helps adults with major depressive disorder. 346 participants were randomly assigned to receive either the medication or a placebo pill for 6 weeks. Researchers measured changes in depression symptoms and monitored for si…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Magic mushroom therapy tested for depression
Disease control CompletedThis small, early-stage study tested whether it is safe and practical to combine psilocybin (the active compound in 'magic mushrooms') with cognitive behavioral therapy (CBT) to treat major depression. Sixteen participants received two doses of psilocybin along with 12 therapy se…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Magic mushroom compound tested as new hope for depression
Disease control CompletedThis study tested if psilocybin, the active compound in 'magic mushrooms,' could help people with major depression. Researchers compared giving psilocybin alone, standard therapy alone, or combining the two. They measured changes in people's depression symptoms, anxiety, and rela…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Brain scans could end antidepressant Trial-and-Error
Diagnosis CompletedThis study aimed to help doctors choose the right antidepressant for people with depression before they start treatment. Researchers used brain scans, computer tasks, and questionnaires to find markers that predict whether a person would respond better to one of two common antide…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE4 • Sponsor: Mclean Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:31 UTC
-
New therapy aims to save young lives by fixing sleep and brain patterns
Prevention CompletedThis Yale University study tested a new therapy designed to prevent suicide in adolescents and young adults with depression or bipolar disorder. The therapy teaches self-help strategies to create more regular daily routines, especially for sleep, with the goal of improving brain …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Mar 30, 2026 14:30 UTC
-
Brain scans reveal if laughing gas lifts depression
Symptom relief CompletedThis small pilot study explored whether inhaling nitrous oxide (laughing gas) weekly could improve symptoms of major depression. Researchers used MRI brain scans to see if the treatment changed brain activity and connections in 11 participants. They compared laughing gas to a sed…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Apr 04, 2026 00:21 UTC
-
Could a gentle touch ease depression? new study explores massage therapy
Symptom relief CompletedThis study tested whether gentle massage therapy could help reduce symptoms of depression. 25 adults with depression received weekly 30-minute massage sessions focused on the head, neck, and shoulders for 8 weeks. Researchers measured changes in depression and physical symptom sc…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Corewell Health South • Aim: Symptom relief
Last updated Apr 04, 2026 00:20 UTC
-
Magic mushroom microdoses tested as mood lifter
Symptom relief CompletedThis study tested whether taking very small, non-hallucinogenic doses of psilocybin (the active compound in 'magic mushrooms') could safely improve mood in people with major depression. It involved 39 adults who either hadn't responded to standard treatments or didn't want to try…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Rotem Petranker • Aim: Symptom relief
Last updated Apr 04, 2026 00:20 UTC
-
Blood pressure battle: which anesthesia is safer during shock therapy?
Symptom relief CompletedThis study compared two anesthesia methods used during electroconvulsive therapy (ECT) for severe depression. Researchers tested whether a combination drug (ketofol) helps maintain more stable blood pressure than the commonly used propofol alone. The trial involved 80 adults rece…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Fauji Foundation Hospital • Aim: Symptom relief
Last updated Apr 04, 2026 00:20 UTC
-
Can cutting junk food help ease depression? small study tests the idea
Symptom relief CompletedThis small pilot study explored whether it's practical and acceptable for people with depression to reduce the amount of ultra-processed foods in their diet. Researchers worked with 20 adults who had major depressive disorder and typically ate a lot of processed foods. The main g…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
Thinking skills training tested to ease mental health symptoms
Symptom relief CompletedThis study tested whether a special group training program could help people with mental health conditions. The program, called Metacognitive Training, aimed to teach new thinking skills to reduce symptoms like depression, anxiety, and distorted thoughts. Researchers worked with …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: ZI-YU LIN • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
Can Sunlight-Mimicking hospital lights lift depression?
Symptom relief CompletedThis study tested whether a new dynamic lighting system installed in hospital rooms could help reduce symptoms of depression. The special lights were designed to mimic natural sunlight, changing color and brightness throughout the day to help regulate sleep-wake cycles. Researche…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New virtual therapy aims to help veterans at high risk for suicide
Symptom relief CompletedThis study tested a 10-week telehealth program designed to help veterans with major depression and a history of suicide attempts. The program used online brain-training exercises and problem-solving practice to improve decision-making and manage depression symptoms. Researchers w…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Can therapy train your brain to stop unwanted thoughts?
Symptom relief CompletedThis study tested whether a specific type of talk therapy could help people with obsessive-compulsive disorder (OCD), anxiety, or depression who struggle with repetitive, unwanted thoughts. The therapy aimed to teach better attention control skills to help people shift away from …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
VA study tests One-Size-Fits-All therapy against standard treatments
Symptom relief CompletedThis study compared two types of talk therapy for veterans with PTSD, depression, or panic disorder. Researchers tested if a single, streamlined therapy could work as well as separate, disorder-specific therapies. 304 veterans received 12 weeks of either the new combined approach…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Could a workout before therapy be the key to better depression treatment?
Symptom relief CompletedThis study tested whether doing 30 minutes of moderate exercise right before therapy sessions could make cognitive behavioral therapy (CBT) work better for depression. Researchers compared 40 adults with depression who either exercised or rested quietly before their weekly therap…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New hope for uncontrollable movements? drug study aims to ease debilitating side effect
Symptom relief CompletedThis study tested whether the drug valbenazine could improve daily life for people with tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to certain mental health medications. For 24 weeks, 59 adults with TD and conditions like schizophrenia or bi…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Natural hormone tested as new hope for menopause blues
Symptom relief CompletedThis study tested if pregnenolone, a natural hormone sold as a supplement, could help reduce depression in women during or after menopause. Researchers compared pregnenolone to a placebo pill in 73 women to see if it improved mood, anxiety, hot flashes, and thinking skills. The g…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Headsets for healing: can VR make depression treatment better?
Symptom relief CompletedThis study tested whether using a virtual reality (VR) headset could help people with depression get more out of a common talk therapy. Researchers compared standard therapy to therapy enhanced with VR activities. The main goal was to see if the VR approach was practical, accepta…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Personalized pills: can your DNA pick a better antidepressant?
Symptom relief CompletedThis study tested if using a patient's genetic information (DNA) to guide the choice of antidepressant medication works better than standard doctor-led care for cancer patients. 99 adults with cancer and symptoms of depression or anxiety were randomly assigned to either get a DNA…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Zapping away depression? new brain treatment tested for seniors
Symptom relief CompletedThis study tested a non-drug treatment for depression in people over 60. Researchers used a magnetic device to gently stimulate specific areas of the brain, aiming to improve mood. They compared the real treatment to a fake (placebo) version in 108 participants to see if it safel…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Can 17th-Century music soothe modern anxiety?
Symptom relief CompletedThis study explored whether listening to Baroque music could help reduce anxiety in people with major depressive disorder. Eighteen participants listened to a 30-minute playlist of Baroque pieces during a clinic visit. Researchers measured their anxiety levels before and after to…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Symptom relief
Last updated Mar 16, 2026 15:26 UTC
-
Magic mushroom compound tested for dual mental health conditions
Symptom relief CompletedThis small, completed study from the University of Chicago explored whether a single dose of psilocybin, the active compound in 'magic mushrooms,' could safely reduce symptoms in adults diagnosed with both major depression and borderline personality disorder. Nine participants re…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC
-
Can sweating it out in hot yoga ease depression?
Symptom relief CompletedThis study tested whether taking heated yoga classes could help adults with mild to moderate depression feel better. Researchers enrolled 80 people to either participate in twice-weekly hot yoga sessions or wait for treatment while tracking their symptoms. The main goals were to …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC
-
Diabetes drug tested to clear 'Brain Fog' in depression
Symptom relief CompletedThis study tested whether adding the medication semaglutide to standard depression treatment could improve cognitive problems like poor memory and concentration. It involved 72 overweight adults with major depression who reported these thinking difficulties. Participants received…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Mar 06, 2026 15:37 UTC
-
First human test of new depression pill checks safety
Knowledge-focused CompletedThis early-stage study aimed to check the safety and tolerability of a new oral drug called AGN-241751 (zelquistinel) in healthy people. Researchers gave 68 healthy volunteers single, increasing doses of the drug or a placebo to see how their bodies reacted and processed it. The …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1 • Sponsor: Syndeio Biosciences, Inc • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Scientists scan brains to unlock the chemical secrets of depression
Knowledge-focused CompletedThis study aims to understand how brain chemistry differs in people with depression, PTSD, and bipolar disorder. Researchers will use MRI and PET scans to measure specific brain chemicals in 180 participants, comparing those with the conditions to healthy volunteers. The goal is …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists scan teen brains to predict depression before it starts
Knowledge-focused CompletedThis study aimed to understand what might predict depression in teenage girls by looking at their genes and brain activity. It involved 100 healthy girls aged 12-14, some with a family history of depression, who completed interviews, computer tasks, and one brain scan over six mo…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC
-
Scientists probe Brain's sugar link to teen depression
Knowledge-focused CompletedThis study aimed to understand if the brain's response to insulin is different in teens with depression. Researchers compared brain scans of 12 adolescents with depression to 12 healthy teens after giving them a nasal spray containing either insulin or a placebo. The goal was to …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:40 UTC
-
Could treating mom or Dad's blues ease a Child's asthma?
Knowledge-focused CompletedThis study looked at whether improving a caregiver's depression could lead to better asthma control for their child. Researchers followed 205 caregiver-child pairs for one year, measuring depression and asthma symptoms regularly. The goal was to understand the connection between …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Can a hunger hormone give people with depression more drive?
Knowledge-focused CompletedThis study tested if giving people the natural hunger hormone ghrelin could increase their motivation to work for rewards and change how their body uses energy. It involved 24 people, including some with major depression and some healthy volunteers. Participants received either g…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Can a hunger hormone give you more drive? brain study investigates
Knowledge-focused CompletedThis study aimed to understand if a hormone from the stomach called ghrelin can increase a brain chemical (dopamine) and boost a person's willingness to work hard for rewards. Researchers gave ghrelin or a placebo to 26 healthy people and people with depression, then used brain s…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Scientists hunt for blood test to predict antidepressant success
Knowledge-focused CompletedThis study aimed to find biological markers that could predict who will respond well to the antidepressant venlafaxine. Researchers followed 60 people with major depression and 20 healthy volunteers for three months. They measured specific proteins in the blood and linked them to…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE4 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
Scientists search for Brain's suicide warning signs
Knowledge-focused CompletedThis study aimed to find biological markers, or signs, that could help predict suicide risk in people with major depression. Researchers used brain scans, thinking tests, and behavioral tasks to measure how people process pain, reward, and attention. They followed 97 adults with …
Matched conditions: MAJOR DEPRESSIVE DISORDER
Sponsor: Unity Health Toronto • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists map how depression changes your Body's emotional reactions
Knowledge-focused CompletedThis study aimed to understand how depression affects the body's physical responses and brain activity during emotional experiences. Researchers compared 76 women—some currently depressed, some recovered from depression, and some healthy—measuring heart rate, breathing, skin resp…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists probe hidden link between daily stress and future brain fog
Knowledge-focused CompletedThis small pilot study aimed to understand how everyday stress might affect heart and blood vessel health, and whether this could be a reason for future memory or thinking problems. Researchers studied 17 middle-aged adults, some with depression, tracking their daily stress for t…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of Delaware • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Scientists hunt for clues to predict postpartum depression
Knowledge-focused CompletedThis study aimed to understand what causes mood episodes like depression after childbirth. Researchers followed 300 pregnant women, some with and some without a history of mood disorders, to track their mental health. They collected information on genes, hormones, stress, and sle…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC
-
Research links poverty, stress, and depression to higher heart disease risk
Knowledge-focused CompletedThis study aimed to understand how social and economic factors—like income, stress, and depression—affect heart and blood vessel health in minority communities at higher risk for health disparities. Researchers enrolled 105 adults to complete surveys about their life experiences,…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Scientists zap brains to unlock Depression's secrets
Knowledge-focused CompletedThis study aimed to understand how the brain's reward system influences responses to depression treatments. Researchers tested 120 adults with depression using non-invasive brain stimulation and two different medications to see how they affected brain activity during a reward tas…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: PHASE4 • Sponsor: Marta Peciña, MD PhD • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC
-
Scientists probe gut and brain links to depression treatment
Knowledge-focused CompletedThis study aimed to understand how depression and antidepressant treatment affect natural brain chemicals and gut bacteria. Researchers compared 228 adults with depression to healthy adults, measuring blood chemicals, memory, mood, and stool samples over 8 weeks of antidepressant…
Matched conditions: MAJOR DEPRESSIVE DISORDER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC